Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
13.68
+0.03 (0.22%)
Oct 23, 2026, 3:00 PM CST
SHA:600513 Market Cap
SHA:600513 has a market cap or net worth of 3.91 billion as of October 23, 2026. It is the 13,649th most valuable company in the world and the 3,501st biggest in China. Its market cap has decreased by 32.58% in one year.
Market Cap
3.91B
Enterprise Value
5.73B
Revenue
3.00B
Global Rank
Country Rank
#3,501 China
PE Ratio
n/a
ChartMarket Cap Chart
Since March 19, 2003, SHA:600513's market cap has increased from 1.11B to 3.91B, an increase of 250.67%. That is a compound annual growth rate of 5.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.91B | -25.29% |
| Dec 31, 2025 | 5.23B | 84.76% |
| Dec 31, 2024 | 2.83B | -11.04% |
| Dec 29, 2023 | 3.18B | 17.94% |
| Dec 30, 2022 | 2.70B | -3.08% |
| Dec 31, 2021 | 2.78B | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jianmin Pharmaceutical Group | 4.06B |
| Tianjin Lisheng Pharmaceutical | 4.06B |
| Zhongzhu Healthcare Holding Co.,Ltd | 4.00B |
| LanZhou Foci Pharmaceutical | 3.94B |
| Jinling Pharmaceutical Company | 3.87B |
| ChengDa Pharmaceuticals | 3.85B |
| Nanjing Hicin Pharmaceutical | 3.85B |
| Hunan Hansen Pharmaceutical | 3.81B |